AIDS Reviews

Papers
(The TQCC of AIDS Reviews is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Beating HIV from day 1: strengthening same-day antiretroviral therapy in South Africa: challenges, realities, and the path forward18
Central nervous system disorders in HIV-infected individuals using distinct antiretroviral drugs16
Lenacapavir Ó? a strong weapon to accelerate HIV prevention15
Antiretroviral therapy Ó?à la carteÓ�15
Mental Health Crisis in the Youth and Rebound in Sexually Transmitted Infections14
The role of nurses in the prevention of anal cancer in HIV-infected men having sex with men – a focus on papillomavirus vaccination and anal cytology screening13
Obelisks Ó Newly discovered virus-like particles11
Relationship between cytokine storm and SARS-CoV-2 infection’s worsening10
Global incidence of chlamydia infection and HIV pre-exposure prophylaxis10
Avian influenza in the context of a pandemic challenge10
Nutritional assessment in the HIV-infected older population receiving antiretroviral therapy9
Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives9
Unraveling the complex interplay: HIV and male infertility7
HIV-1 infection and the hematopoietic microenvironment7
Rapid antigen Testing and Mask Wearing While Waiting for COVID-19 Vaccines7
Behavioral interventions for tobacco use in HIV-infected smokers: systematic review and pairwise, network meta-analysis of randomized trials7
International HTLV Conference, London, June 3-5, 20247
Evolution of Experimental Design and Research Techniques in HIV-1 Reservoir Studies: A Systematic Review6
Prevalence and risk factors for HIV infection in truck drivers: a systematic review of global evidence6
Research on differences in sexual orientation and identity6
Risk factors and mortality outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis5
HTLV European Research Network 2023: the silent pandemic of HTLV-1 infection5
Impact of New Coronavirus Epidemics on HIV-Infected Patients5
Off-label use of antiretroviral drugs: ethical and legal implications for clinical decision-making5
Safety of Antiretroviral Therapy in the Treatment of HIV/AIDS in Children: Systematic Review and Meta-analysis5
COVID-19 Comes 40 Years After AIDS – Any Lesson?4
The impact of the M184V resistance mutation on treatment outcomes in patients with HIV infection: a systematic review and meta-analysis4
Acquired syphilis in the context of pre-exposure prophylaxis for HIV: a systematic review of the scientific literature4
The opioid epidemic during the COVID-19 pandemic: Impact on HIV and HCV control4
The new profile of psychiatric disorders in patients with HIV infection4
The management of polypharmacy in people living with HIV4
Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era – Reflections Looking Forward3
Adherence to antiretroviral therapy among HIV-1 patients from sub-Saharan Africa: a systematic review3
A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice3
Mitochondrial damage as cause of long COVID3
New SARS-CoV-2 Variants Challenge Vaccines Protection3
Early and contemporary drivers of the HIV-1 group M pandemic3
Humanized mouse models for preclinical evaluation of HIV cure strategies3
HIV-1 genotyping and drug resistance mutations in Morocco (2009-2024): a systematic review addressing critical gaps in molecular surveillance3
Systematic review and meta-analysis of risk prediction models for HIV testing in key populations3
Coinfection with Viral Hepatitis in HIV patients in 20233
0.053997039794922